the identification of the threat agent, 
emergency, or the biomedical counter-
measure with respect to which the author-
ity was used; 
(ii) the reasons underlying the deci-
sion to use such authorities, including, as 
applicable, the options that were consid-
ered and rejected with respect to the use of 
such authorities; and 
(iii) the identification of each person 
or entity that received, or was considered 
and rejected for, grants, cooperative agree-
ments, or contracts pursuant to the use of 
such authorities. 
(2) ANNUAL SUMMARIES REGARDING CERTAIN 
ACTIVITY.—The Secretary shall annually submit to 
the Congress a report that summarizes the activity 
undertaken pursuant to the following authorities 
under section 319F–1 of the Public Health Service 
Act (as added by section 2 of this Act): 
(A) Subsection (b)(3) (relating to in-
creased micropurchase threshold). 
(B) Subsection (d) (relating to authority 
for personal services contracts).
(C) Subsection (e) (relating to streamlined 
personnel authority). 
With respect to subparagraph (B), the report shall 
include a provision specifying, for the one-year pe-
riod for which the report is submitted, the number 
of persons who were paid amounts greater than 
$100,000 and the number of persons who were paid 
amounts between $50,000 and $100,000. 
(b) NATIONAL ACADEMY OF SCIENCES REVIEW.—
Not later than three years after the date of the enactment 
of this Act, the Secretary of Health and Human Services 
shall request the National Academy of Sciences to enter 
into an agreement for a review of the biomedical counter-
measure research and development authorities established 
in this Act to determine whether and to what extent activi-
ties undertaken pursuant to such authorities have en-
hanced the development of biomedical countermeasures af-
fecting national security, and to recommend any legislative 
or administrative changes necessary to improve the ability 
of the Secretary to carry out these activities in the future. 
The Secretary shall ensure that the results of the study 
are submitted to the Congress not later than five years 
after such date of enactment. 
(c) GENERAL ACCOUNTING OFFICE REVIEW.—Four 
years after the date of the enactment of this Act, the
Comptroller General of the United States shall initiate a 
study—
(1)(A) to review the Secretary of Health and 
Human Services’ utilization of the authorities grant-
ed under this Act with respect to simplified acquisi-
tion procedures, use of noncompetitive procedures, 
increased micropurchase thresholds, personal serv-
ices contracts, streamlined personnel authority, and 
the purchase of security countermeasures under the 
special reserve fund; and 
(B) to recommend any legislative or administra-
tive changes necessary to improve the utilization or 
effectiveness of such authorities in the future; 
(2)(A) to review the internal controls instituted 
by such Secretary with respect to such authorities, 
where required by this Act; and 
(B) to recommend any legislative or administra-
tive changes necessary to improve the effectiveness 
of such controls; and 
(3)(A) to review such Secretary’s utilization of 
the authority granted under this Act to authorize an 
emergency use of a biomedical countermeasure, in-
cluding the means by which the Secretary deter-
mines whether and under what conditions any such 
authorizations should be granted and the benefits
and adverse impacts, if any, resulting from the use 
of such authority; and 
(B) to recommend any legislative or administra-
tive changes necessary to improve the utilization or 
effectiveness of such authority and to enhance pro-
tection of the public health. 
The results of the study shall be submitted to the Con-
gress not later than five years after the date of the enact-
ment of this Act.
Æ